Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.8.0.1
Equity (Details)
 3 Months Ended
Mar. 31, 2018
USD ($)
$ / shares
shares
Summary of warrant activities  
Number of Units, Granted 387,230
Warrant [Member]  
Summary of warrant activities  
Number of Units, Outstanding, Beginning balance 25,662,340
Number of Units, Granted 30,241,538
Number of Units, Exercised
Number of Units, Cancelled
Number of Units, Outstanding, Ending balance 55,903,878
Number of Units, Exercisable 55,708,878
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares $ 1.89
Weighted Average Exercise Price, Granted | $ / shares 1.23
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares 1.23
Weighted Average Exercise Price, Exercisable | $ / shares $ 1.21
Weighted Average Remaining Contractual Term (in years), Outstanding, Beginning balance 3 years 7 months 13 days
Weighted Average Remaining Contractual Term (in years), Granted 2 years 1 month 16 days
Weighted Average Remaining Contractual Term (in years), Outstanding, Ending balance 2 years 7 months 28 days
Weighted Average Remaining Contractual Term (in years), Exercisable 2 years 7 months 28 days
Aggregate Intrinsic Value, Outstanding, Beginning balance | $ $ 995,373
Aggregate Intrinsic Value, Outstanding, Ending balance | $ 546,959
Aggregate Intrinsic Value, Exercisable | $ $ 546,959